The Next Frontier in Cardiac Monitoring
The wearable revolution has transformed cardiac monitoring. Continuous ECG, heart rate tracking, recovery scores, stress indicators — data is no longer scarce.
But more data does not equal deeper insight.
Most consumer and even many clinical systems focus on rhythm timing — heart rate and heart rate variability (HRV). These metrics describe autonomic modulation and beat-to-beat fluctuations. They are undoubtedly valuable.
However, they do not describe the stability of electrical excitation of the myocardium.
There is a fundamental distinction between just measuring temporal characteristics of heart beats and understanding how the heart recovers electrically after each beat. That distinction defines the next frontier of cardiac analytics.
RR Interval vs. QT Interval — A Critical Difference

Figure 1: Fundamental difference between RR (rhythm timing) and QT (electrical recovery) intervals.
The RR interval measures the time between consecutive ventricular depolarizations. It reflects:
- Heart rate
- Autonomic nervous system influence
- Rhythm irregularity
RR variability forms the basis of HRV.
However, the RR interval captures exclusively the timing, leaving the essence of the physiological process itself out of the picture.
The QT interval describes the full cycle of ventricular electrical depolarization and repolarization which defines stages of contraction and relaxation of the myocardium. QT interval reflects ion-channel behavior, cellular electrophysiology, and tissue-level electrical dynamics.
Importantly, QT is not static.
It adapts to heart rate.
This dynamic adaptation — the QT/RR relationship — contains far deeper physiological information than a single corrected QT value ever could.
From QT/RR Dynamics to Reserve of Repolarization (RoR)
Traditional drug-safety paradigms focus on QT prolongation as an isolated endpoint. However, electrical stability is not defined by a single measurement.
The fundamental approach at Monebo Technologies is built on analyzing:
- The rate (slope) of QT adaptation across different heart rates
- The curvature and stability of the QT/RR dynamics
- Behavior across physiological and circadian ranges
Using this dynamic model, we employ the Reserve of Repolarization (RoR) patented by University of North Carolina at Greensboro technology (US patent No.10,076,259, 2018) which provides a quantitative measure of how robustly ventricular repolarization adapts to changes in heart rate.
RoR is not a replacement for QT interval measurements.
It is a systems-level interpretation of repolarization behavior.
It reflects electrical resilience — the myocardium’s adaptive reserve to recover under changing physiological conditions.
HRV, AFib, and Ventricular Stability — Different Layers of Risk
Modern messaging often conflates distinct electrophysiological phenomena:
- HRV → autonomic balance
- AFib detection → atrial rhythm instability
- QT dynamics → ventricular electrical stability
These operate at different physiological layers.
Stroke risk associated with atrial fibrillation arises from atrial mechanical dysfunction and thromboembolism. Malignant ventricular arrhythmias arise from repolarization instability.
The nature of these mechanisms is fundamentally different, and substituting one for the other is inherently incorrect.
Wearables focused solely on HRV cannot assess ventricular electrical reserve. Static QT measurement without dynamic modeling does not capture adaptation behavior. RoR elegantly and precisely addresses this systemic industry gap.
Circadian Mapping of Electrical Behavior
Electrical stability of myocardium is not constant throughout the day.
Using long-term ambulatory ECG data, algorithms map QT/RR dynamics across circadian cycles. This approach allows the visualization of how repolarization reserve shifts:
- During sleep
- Under physical exertion
- During stress activation
- Throughout the recovery period

Figure 2: Colored background RoR/RR map includes hundreds of averaged over total observation time ECG signals recorded by Samsung Galaxy Watch. Published variations of RoR/RR data are shown as geometrical shapes corresponding to RoR values measured before (orange) and after (black) four weeks Yoga relaxation training (stars); a month of exertion exercise in men (rhomb) and women (circle); and recovery from stress in firefighters awakening on alarm call
This is not simply signal analysis. It is electrophysiological phenotyping — characterizing the dynamic electrical profile of the heart in real-world conditions.
Novel Clinical Insights

Figure 3: The Kinetic™ framework translates raw ECG signals into precise, clinical-grade electrophysiological data.
Clinical-grade interpretation of RoR requires accurate beat detection, robust QT delineation, artifact rejection, and statistical validation as shown in Fig. 3.
Hardware captures signals. Intelligent algorithms determine clinical value.
The Science Behind the Framework
The heart is an excitable nonlinear medium governed by reaction–diffusion dynamics. Understanding repolarization requires theoretical electrophysiology, computational modeling, and empirical validation.
The development of analytically solvable reaction–diffusion models of wave propagation in excitable tissue — including the Chernyak–Starobin–Cohen model — provided theoretical insight into the mechanisms of arrhythmogenesis and electrical instability.
RoR is based on this scientific foundation. It is not merely an additional feature. It is a comprehensive framework for quantifying electrical resilience.
From Variability to Resilience
The industry has mastered variability.
The next stage of evolution is resilience.
Reserve of Repolarization represents a shift:
- From static measurements to dynamic adaptation
- From rhythm description to a profound understanding of electrical processes
Cardiac monitoring is no longer just about detecting irregularities. Its goal is understanding stability.
Elevate Your Devices to the Next Level of Analytics
Discover how the Kinetic™ family of algorithms (including Kinetic™ Rhythms, Intervals, and AF) provides medical device developers with unparalleled data accuracy.

